FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen receptor pathway inhibitor (ARPI)-treated, taxane-naïve metastatic castration-resistant prostate cancer (mCRPC), led to a median radiographic progression free survival (rPFS) of 7.0 months in the overall study cohort, with median rPFS of 10.1 months observed in patients who progressed on only one prior ARPI Higher […]
Category Archives: Pr Newswire
Pr Newswire
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
24
Feb
Feb
Favorable safety and tolerability profile with no Grade 3 or greater treatment-related adverse events Company expects to complete enrollment of the BCG-Unresponsive cohort of the ADVANCED-2 trial in 2H 2026 Company to host conference call and webcast tomorrow at 8:00 a.m. ET NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), […]
Pr Newswire
Palvella Therapeutics to Host Conference Call to Discuss Topline Results from Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic Lymphatic Malformations
24
Feb
Feb
Webcast conference call to take place tomorrow, Tuesday, February 24, 2026, at 8:00am ET WAYNE, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) — (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which […]
– Operated promotional booth at Japan’s largest food and retail exhibition from Feb. 18–20, attracting approximately 10,000 visitors over three days– Promoted K-food with Jongga and O’food brands; four tasting menus reflecting local food trends received favorable reviews SEOUL, South Korea, Feb. 24, 2026 /PRNewswire/ — Daesang announced on the 23rd that it successfully concluded […]
Strategic preferred partnership expands progress claims and early payment solutions across Australia and New Zealand construction sector SYDNEY, Feb. 24, 2026 /PRNewswire/ — Earlytrade, the global fintech platform transforming working capital management, today announced an ANZ strategic preferred partnership with BuildingPoint Australia to expand progress claims and structured early payment solutions across the construction supply […]
NEW YORK, Feb. 24, 2026 /PRNewswire/ — iScooter, an innovator dedicated to personal transportation solutions, has launched its Spring Sale electric scooter campaign across the United States and Canada, running from February 27 to March 26, 2026, as warmer weather drives renewed demand for efficient, low-carbon mobility on campuses and in urban environments. Students and young […]
Hornet is lightweight yet powerful—Now Live on Kickstarter LOS ANGELES, Feb. 24, 2026 /PRNewswire/ — Three Times Lighter, Zero Fatigue Weighing just 450 grams — approximately one-third the weight of many conventional spray guns — Hornet is designed for extended, fatigue-free use. The palm-sized frame allows one-handed operation without wrist strain, making it suitable for […]
Cumulative SVNet Deployment Nears 5 Million Vehicles Worldwide Significant volume deployed in 2025, reflecting strong commercial momentum Growth Driven by Multi-Year Business Maturation and Expanded Mass Production Programs SEOUL, South Korea and SHANGHAI, Feb. 24, 2026 /PRNewswire/ — STRADVISION, a global pioneer in AI-powered vision perception technology, today announced that cumulative commercial production deployments of its flagship […]
Pr Newswire
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
23
Feb
Feb
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr. Maynard joins Foghorn with […]
23
Feb
Feb
WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in a webcast fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 9:50 a.m. ET. The live conference webcast will be posted on the “Events and Presentations” […]